Porous carrier matrix
AssigneeBioventus, LLC
InventorsChristopher Wilson, Eric Vanderploeg, Cheryl Lee, Chase Davis, Howard Seeherman, John Wozney
Life of this patent
Estimating the term…
Abstract
Medical devices, substrates and biologic therapies for bone repair and guided tissue regeneration are disclosed. More particularly, bone graft substitutes and bone void fillers which comprise a porous collagen matrix and calcium deficient hydroxyapatite ceramic granules for delivery of osteoinductive or other therapeutic agents are disclosed.
Claims6
A composition comprising a plurality of porous CDHA granules comprising macropores and micropores, said granules having a diameter in the range of from 425 to 800 μm, a specific surface area of greater than 50 m2/g, a surface roughness (Ra) of at least 2.2 μm and a pH of 3.5 to 6.5;
- and wherein said plurality of granules has a tap density of less than 700 mg/cc;
- wherein said plurality of granules is admixed with a biocompatible matrix comprising an acidic collagen gel and an alkaline collagen powder, and wherein the collagen gel and collagen powder are present in the biocompatible matrix at a 1:1 ratio by dry mass.
A bone graft substitute comprising a biocompatible porous carrier matrix comprising an acidic collagen gel and an alkaline collagen powder, wherein the collagen gel and collagen powder are present in the biocompatible matrix at a 1:1 ratio by dry mass and are cross-linked, said matrix having admixed therein a plurality of porous CDHA granules having a tap density of less than 700 mg/cc, and wherein said granules have a diameter in the range of from 425 to 800 μm, a surface roughness (Ra) of at least 2.2 μm and a pH of 3.5 to 6.5;
- and
- wherein said bone graft substitute is sterilized via exposure to E-Beam irradiation or ethyleneoxide.
A method of making a porous carrier matrix comprising the steps of:
- a. Forming a two-phase Type I collagen mixture comprising a water-swelled acidic collagengel and an alkaline collagen powder, and adjusting the mixture to an isotonic condition and neutral pH to form a biocompatible matrix material;
- wherein said collagen gel and collagen powder are mixed at a 1:1 ratio by dry weight;
- b. Adding a plurality of porous CDHA granules having a tap density of less than 700 mg/cc to said biocompatible matrix material to form a composite slurry, wherein said CDHA granules have a diameter of from 425-800 μm and comprise macropores and micropores, a surface roughness (Ra) of at least 2.2 μm, and a pH of 3.5 to 6.5;
- c. Shaping said composite slurry into a desired size and shape to form a shaped composite slurry and lyophilizing the shaped composite slurry to form a lyophilized composite material;
- d. Rehydrating the lyophilized composite material and adding a cross-linking agent to the lyophilized composite material to form a cross-linked composite material;
- and
- e. Lyophilizing the cross-linked composite materials prior to sterilizing the cross-linked composite material via exposure to E-Beam or ethylene oxide to form a sterilized composite material.
Dependencies are inferred from the claim text.